Potlako: A Programmatic Intervention to Improve Access to Timely Oncology Care

HIV Clinical Trial

Official title:

Potlako: A Programmatic Multi-facility Level Intervention to Improve Access to Timely Oncology Care in Botswana

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02752061
• Other study ID #: BHP078
• Status: Completed
• Phase: N/A
• Start date: May 13, 2016
• Est. completion date: July 21, 2020

Study information

• Verified date: July 2020
• Source: Harvard School of Public Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Diagnostic and treatment delays contribute substantially to disparities in cancer morbidity and mortality between low- and middle- income countries (LMICs) and high-income countries. Individuals present with advanced stage disease resulting in minimal chance for cure or long-term survival.

The Potlako project will implement and evaluate a multifaceted intervention to test the hypothesis that a package of enhanced coordination of care including an electronic messaging, transportation support, and training targeted at generalist clinicians at primary and secondary level facilities, can reduce time to diagnosis and stage at diagnosis for HIV-infected individuals with cancer.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 979
• Est. completion date: July 21, 2020
• Est. primary completion date: July 21, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Citizen of Botswana

• Suspected or diagnosed cancer

Exclusion Criteria:

• Involuntary incarceration

Related Conditions & MeSH terms

• Healthcare Disparity
• HIV
• Neoplasms

Intervention

Other:
• Potlako intervention
Multicomponent intervention including: provider training on early detection and diagnostic approaches to cancer patient education on importance of obtaining timely cancer diagnosis provision of a patient navigator to facilitate diagnosis and entry into care provision of transportation support to vulnerable patients

Locations

Country	Name	City	State
Botswana	Botswana Harvard AIDS Institute	Gaborone

Sponsors (5)

Lead Sponsor	Collaborator
Harvard School of Public Health	Botswana Harvard Aids Institute, Botswana Ministry of Health, Brigham and Women's Hospital, Dana-Farber Cancer Institute

Country where clinical trial is conducted

Botswana, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cancer stage		1 day visit
Primary	Time from initial clinic visit with cancer symptom/sign to entry into oncology care		1 day visit